ZENAS BIOPHARMA INC (ZBIO) Stock Cash Flow
NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -128.97M | -37.12M | -119.28M | |||
| Depreciation Amortization | 134.00K | 113.00K | 78.00K | |||
| Change In Working Capital | 24.13M | -8.04M | 7.97M | |||
| Other non cash items | 8.19M | 14.52M | 45.59M | |||
| OPERATING CASH FLOW | -96.52M | -30.53M | -65.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | -74.00K | -17.00K | -2.20M | |||
| INVESTING CASH FLOW | -26.83M | -17.00K | -2.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | N/A | 20.00M | 0.00 | |||
| Stock Issued/Repurchased | 413.02M | 116.00K | 59.39M | |||
| FINANCING CASH FLOW | 411.15M | 20.12M | 59.39M | |||
| Exchange Rate Effect | -71.00K | 78.00K | -41.00K | |||
| CHANGE IN CASH | 287.73M | -10.35M | -8.50M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -96.52M | -30.53M | -65.65M | |||
| Capital Expenditure | -74.00K | -17.00K | -2.20M | |||
| FREE CASH FLOW | -96.59M | -30.55M | -67.85M | |||
All data in USD